Exchange Traded Concepts LLC grew its holdings in USANA Health Sciences, Inc. (NYSE:USNA – Free Report) by 11.3% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 8,578 shares of the company’s stock after buying an additional 869 shares during the quarter. Exchange Traded Concepts LLC’s holdings in USANA Health Sciences were worth $308,000 as of its most recent SEC filing.
Several other large investors have also made changes to their positions in USNA. Martingale Asset Management L P increased its holdings in USANA Health Sciences by 2.1% in the 3rd quarter. Martingale Asset Management L P now owns 16,732 shares of the company’s stock worth $634,000 after acquiring an additional 340 shares in the last quarter. KBC Group NV grew its position in shares of USANA Health Sciences by 96.6% in the third quarter. KBC Group NV now owns 1,056 shares of the company’s stock valued at $40,000 after purchasing an additional 519 shares during the period. Safe Harbor Fiduciary LLC purchased a new stake in shares of USANA Health Sciences during the third quarter worth about $30,000. Franklin Resources Inc. raised its position in shares of USANA Health Sciences by 9.2% during the 3rd quarter. Franklin Resources Inc. now owns 21,050 shares of the company’s stock worth $750,000 after purchasing an additional 1,771 shares during the last quarter. Finally, Harbor Capital Advisors Inc. lifted its stake in USANA Health Sciences by 44.1% in the 3rd quarter. Harbor Capital Advisors Inc. now owns 8,859 shares of the company’s stock valued at $336,000 after buying an additional 2,713 shares in the last quarter. 54.25% of the stock is owned by institutional investors and hedge funds.
Insider Buying and Selling
In other USANA Health Sciences news, Director Gilbert A. Fuller sold 675 shares of the firm’s stock in a transaction that occurred on Monday, November 4th. The shares were sold at an average price of $37.71, for a total value of $25,454.25. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 0.33% of the stock is currently owned by company insiders.
USANA Health Sciences Stock Up 0.7 %
Wall Street Analysts Forecast Growth
USNA has been the subject of several research reports. DA Davidson boosted their price objective on USANA Health Sciences from $35.00 to $38.00 and gave the stock a “neutral” rating in a research note on Thursday, January 2nd. StockNews.com raised USANA Health Sciences from a “buy” rating to a “strong-buy” rating in a research note on Saturday, December 28th.
View Our Latest Analysis on USNA
USANA Health Sciences Profile
USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.
Featured Stories
- Five stocks we like better than USANA Health Sciences
- Roth IRA Calculator: Calculate Your Potential Returns
- How Growth Investors Find High-Growth Stocks and Maximize Returns
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025
- Energy and Oil Stocks Explained
- NVIDIA’s Slide Continues: Can Retail Investors Stop the Fall?
Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.